Himanen Anna-Katriina, Belt Eero, Nevalainen Juha, Hämäläinen Martti, Lehto Matti U K
Rheumatism Foundation Hospital, Heinola, Finland.
Acta Orthop. 2005 Feb;76(1):85-8. doi: 10.1080/00016470510030373.
We report the survival of AGC knee endoprosthesis from the Finnish Arthroplasty Register for 2 indications, osteoarthrosis (OA, 6,306 knees) and rheumatoid arthritis (RA, 2,161 knees) during 1985-1999. Survivorship analysis was performed with revision as an endpoint. We found similar survival rates. In the OA group, survival after 5 years was 97% and it was 94% after 10 years. In the RA group the corresponding figures were 97% and 96%, respectively. There was no significant difference in survival whether or not cement was used for fixation. The revision rates were higher in men and in younger patients.
我们报告了芬兰关节置换登记处1985年至1999年期间，针对两种适应症（骨关节炎（OA，6306例膝关节）和类风湿性关节炎（RA，2161例膝关节））的AGC膝关节假体的生存率。以翻修为终点进行了生存率分析。我们发现了相似的生存率。在OA组中，5年后的生存率为97%，10年后为94%。在RA组中，相应数字分别为97%和96%。无论是否使用骨水泥进行固定，生存率均无显著差异。男性和年轻患者的翻修率较高。
